Cyclerion Therapeutics Inc (CYCN)
2.77
-0.28
(-9.18%)
USD |
NASDAQ |
Apr 24, 16:00
2.98
+0.21
(+7.58%)
After-Hours: 20:00
Cyclerion Therapeutics Cash and Short Term Investments (Quarterly): 7.571M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.571M |
| September 30, 2023 | 9.108M |
| June 30, 2023 | 5.641M |
| March 31, 2023 | 7.169M |
| December 31, 2022 | 13.38M |
| September 30, 2022 | 20.40M |
| June 30, 2022 | 30.32M |
| March 31, 2022 | 41.12M |
| December 31, 2021 | 53.96M |
| September 30, 2021 | 62.50M |
| June 30, 2021 | 70.39M |
| Date | Value |
|---|---|
| March 31, 2021 | 41.43M |
| December 31, 2020 | 54.40M |
| September 30, 2020 | 66.84M |
| June 30, 2020 | 56.46M |
| March 31, 2020 | 67.10M |
| December 31, 2019 | 94.90M |
| September 30, 2019 | 117.03M |
| June 30, 2019 | 141.03M |
| March 31, 2019 | |
| December 31, 2018 | 0.00 |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
5.641M
Minimum
Jun 2023
141.03M
Maximum
Jun 2019
50.57M
Average
53.96M
Median
Dec 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly and Co | 2.928B |
| iBio Inc | 2.788M |
| AbbVie Inc | 12.82B |
| Agile Therapeutics Inc | 2.557M |
| NovaBay Pharmaceuticals Inc | 3.13M |